Sign in

CTA-PB on NYSE

EIDP

EIDP is a US chemical company based in Indianapolis, founded in 1915.1 It is part of Corteva.1 Its shares trade on NYSE under the symbol CTA-PB.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Apr 3, 1915Founded1

Compare with Celanese Corporation, Sealed Air or Kraig Biocraft Laboratories, Inc., or pick any stock.

  • TickerCTA-PB on NYSE1
  • IndustryPlastic Material, Synth Resin/Rubber, Cellulos (No Glass)1
  • HeadquartersIndianapolis1
  • Legal formDelaware corporation1
  • Incorporated inDE4
  • Business address9330 Zionsville Road, Indianapolis, In 462684
  • LEIGLU7INWNWH88J9XBXD453
  • StatusActive3
  • LEI statusIssued and current3
  • Registered addressC/O THE CORPORATION TRUST COMPANY, 19801 Wilmington, United States3
  • Registered withDivision of Corporations, Department of State, 483063

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2016

10.2%Net margin6
-2.1%Revenue growth, 20166
25.1%Return on equity6
0.81×Debt to equity6
$2.3BFree cash flow6

Where the money goes

Where each dollar of revenue went, fiscal 2016

  • Cost of revenue59¢$14.5B
  • Research and development7¢$1.6B
  • Selling, general and admin18¢$4.3B
  • Other costs4¢$908.0M
  • Income tax3¢$744.0M
  • Profit10¢$2.5B

Out of $24.6B in revenue.6

Where each dollar of operating cash went, fiscal 2016

  • Capital spending31¢$1.0B
  • Share buybacks28¢$916.0M
  • Kept or used elsewhere41¢$1.4B

Out of $3.3B of cash from operations.6

Financial statements

Revenue6$24.6B in 2016−13% since 2014
0$10.0B$20.0B$30.0B2014: $28.4B$28.4B20142015: $25.1B$25.1B2015−12%2016: $24.6B$24.6B2016−2%
Net income6$2.5B in 2016−31% since 2014
0$1.0B$2.0B$3.0B$4.0B2014: $3.6B$3.6B20142015: $2.0B$2.0B2015−46%2016: $2.5B$2.5B2016+29%
Fiscal year201420152016
Revenue$28.4B6$25.1B6$24.6B6
Cost of revenue$17.0B6$15.1B6$14.5B6
Research and development$2.0B6$1.9B6$1.6B6
Selling, general and admin$4.9B6$4.6B6$4.3B6
Operating income$6.4B7
Income tax$1.2B6$696.0M6$744.0M6
Net income$3.6B6$2.0B6$2.5B6
Earnings per share$3.956$2.176$2.876
Earnings per share (diluted)$3.926$2.166$2.856

Compare EIDP with another company

Corporate structure

EIDP is part of a group headed by Corteva. 218 entities, 70 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • Corteva Wilmington, Delaware, United States
    • EIDP Indianapolis, Indiana, United States
      • Vylor Inc. Johnston, Iowa, United States
      • Caribou Biosciences, Inc. Stake · Berkeley, California
      • CORTEVA AGRISCIENCE DO BRASIL LTDA. Subsidiary · Barueri, Brazil
      • CORTEVA SERVICES SARL (CORTEVA SERVICES SÀRL) Subsidiary · Versoix, Switzerland
      • DOW AGROSCIENCES SWITZERLAND S.A. Subsidiary · Le Grand-Saconnex, Switzerland
      • Du Pont Company (Singapore) Pte. Ltd. Subsidiary · Singapore, Singapore
      • DUPONT APOLLO (SHENZHEN) LIMITED Subsidiary · Shenzhen, China
      • DuPont de Nemours (Luxembourg) S.a r.l. (DuPont de Nemours (Luxembourg) S.à r.l.) Subsidiary · Contern, Luxembourg
      • DUPONT KABUSHIKI KAISHA Subsidiary · Chiyoda Ku, Japan
      • DUPONT TRADING (SHANGHAI) CO., LTD. Subsidiary · Shanghai, China
      • PIONEER HI-BRED (SWITZERLAND) SA Subsidiary · Versoix, Switzerland
      • PIONEER HI-BRED INTERNATIONAL, INC. Subsidiary · Johnston, Iowa, United States
      • PIONEER HI-BRED PRIVATE LIMITED Subsidiary · Hyderabad, India
    • Pioneer Hi-Bred Subsidiary · Johnston
    • Agrigenetics, Inc. Subsidiary · Delaware, United States
    • Agro Corteva Chile S.A. Subsidiary · Chile
    • Agro Corteva Colombia, S.A. Subsidiary · Colombia
    • Agro Cultivos Corteva Chile S.A. Subsidiary · Chile
    • AgroStollerec S.A. Subsidiary · Ecuador
    • AgSurf Corporation Subsidiary · Delaware, United States
    • AgVenture, Inc. Subsidiary · Indiana, United States
    • Christiana Insurance LLC Subsidiary · Delaware, United States
    • Corteva (China), LLC Subsidiary · Delaware, United States
    • Corteva Agriscience (Cambodia) Co., Ltd. Subsidiary · Cambodia
    • Corteva Agriscience (Malaysia) Sdn. Bhd. Subsidiary · Malaysia
    • Corteva Agriscience (Myanmar) Company Limited Subsidiary · Myanmar
    • Corteva Agriscience (Singapore) Pte. Ltd. Subsidiary · Singapore
    • Corteva Agriscience (Thailand) Co., Ltd. Subsidiary · Thailand
    • Corteva Agriscience Argentina S.R.L. Subsidiary · Argentina
    • Corteva Agriscience Australia PTY Ltd Subsidiary · Australia
    • Corteva Agriscience Austria GmbH Subsidiary · Austria
    • Corteva Agriscience Bangladesh Limited Subsidiary · Bangladesh
    • Corteva Agriscience Belgium B.V. Subsidiary · Belgium
    • Corteva Agriscience Bolivia S.A. Subsidiary · Bolivia
    • Corteva Agriscience Bulgaria EOOD Subsidiary · Bulgaria
    • Corteva Agriscience Canada Company Subsidiary · Nova Scotia, Canada
    • Corteva Agriscience Chile Limitada Subsidiary · Chile
    • and 175 more

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

What it owns

What EIDP reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$13.9B9 Dec 31, 2018$12.9B9 Dec 31, 2017+8.0%
Accumulated depreciation$1.7B9 Dec 31, 2018$443.0M9 Dec 31, 2017+288.3%
Property and equipment, net$12.2B9 Dec 31, 2018$12.4B9 Dec 31, 2017−2.0%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$4.5B9 Dec 31, 2018$7.2B9 Dec 31, 2017−38.4%
Marketable securities, current$34.0M9 Dec 31, 2018$952.0M9 Dec 31, 2017−96.4%
Stakes in other companies (equity method)$1.4B9 Dec 31, 2018$1.6B9 Dec 31, 2017−13.4%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$40.7B9 Dec 31, 2018$45.6B9 Dec 31, 2017−10.8%
Intangible assets, net (excluding goodwill)$26.1B9 Dec 31, 2018$27.7B9 Dec 31, 2017−6.0%
Indefinite-lived intangibles (excluding goodwill)$11.6B9 Dec 31, 2018$11.8B9 Dec 31, 2017−2.0%
Finite-lived intangibles, gross$16.2B9 Dec 31, 2018$16.3B9 Dec 31, 2017−1.1%
Accumulated amortization-$1.7B9 Dec 31, 2018-$389.0M9 Dec 31, 2017−324.4%
Finite-lived intangibles, net$14.5B9 Dec 31, 2018$15.9B9 Dec 31, 2017−9.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$7.4B9 Dec 31, 2018$8.6B9 Dec 31, 2017−14.2%
Raw materials$481.0M9 Dec 31, 2018$371.0M9 Dec 31, 2017+29.6%
Work in process$1.8B9 Dec 31, 2018$2.8B9 Dec 31, 2017−36.1%
Finished goods$4.2B9 Dec 31, 2018$4.5B9 Dec 31, 2017−6.6%
Supplies$441.0M9 Dec 31, 2018$447.0M9 Dec 31, 2017−1.3%

Properties, in its own words

The company operates out of its headquarters in Indianapolis, Indiana. It also maintains a global business center in Johnston, Iowa, for its Seed business. Its manufacturing, processing, marketing and research and development facilities, as well as regional purchasing offices and distribution centers, are located throughout the world. The company has 95 production sites in the following geographic regions:

Number of Sites

The rest of Item 2

Seed · Crop Protection · Total

North America 1 · 38 · 7 · 45

EMEA 2 · 12 · 9 · 21

Latin America · 8 · 13 · 21

Asia Pacific · 3 · 5 · 8

Total · 61 · 34 · 95

1. North America consists of U.S. & Canada.

2. Europe, Middle East, and Africa ("EMEA").

The company's principal sites include facilities which, in the opinion of management, are suitable and adequate for their use and have sufficient capacity for the company's current needs and expected near-term growth. Properties are either owned by the company or leased, in such cases typically under a long-term lease. No title examination of the properties has been made for the purpose of this report and certain properties are shared with other tenants under long-term leases.

Item 2 of the 10-K filed Feb 12, 2026.10

Leadership

Who has led EIDP, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Charles O. Holliday, Jr.2003–2008
  2. Ellen Kullman2009–2015
  3. Edward D. Breen2015–2017
  4. Jim Collins2019

Chair

  1. Charles O. Holliday, Jr.2003–2008
  2. Ellen Kullman2010–2015
  3. Edward D. Breen2015–2017

President

  1. Ellen Kullman2008

Chief financial officer

  1. Gary M. Pfeiffer2003–2007
  2. Jeffrey L. Keefer2006–2009
  3. Nicholas C. Fanandakis2009–2017
  4. Gregory R. Friedman2019
197019801990200020102020
Board members and other officers (53)

Subsidiaries and ownership

Parent company

Subsidiaries (GLEIF)

From Wikidata.1 Ownership links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); each one cites its LEI record.

Former names

  • DUPONT E I DE NEMOURS & COJan 6, 1994 to Nov 4, 20224
  • E. I. du Pont de Nemours and Companyuntil 20221

Timeline

  1. May 14, 20258-K Other events71
  2. Feb 6, 20258-K Earlier financial statements no longer reliable72
  3. Jun 10, 2019New chief executive Jim Collins becomes CEO11
  4. 2019Acquired Acquired by Corteva1
  5. Nov 10, 2015New chief executive Edward D. Breen becomes CEO12
  6. Jan 27, 2009New chief executive Ellen Kullman becomes CEO13
  7. Sep 16, 2003New chief executive Charles O. Holliday, Jr. becomes CEO14
  8. 1970Went public Listed on NYSE1
  9. Apr 3, 1915Founded Founded1

Filings

8 filings to the SEC since October 2021: 2 major events, 6 other. The latest 8:

  1. May 14, 20258-K EDGAR
  2. May 13, 2025424B2 EDGAR
  3. May 12, 2025FWP EDGAR
  4. May 12, 2025424B5 EDGAR
  5. Feb 6, 20258-K EDGAR
  6. May 12, 2023424B2 EDGAR
  7. May 11, 2023FWP EDGAR
  8. May 11, 2023424B5 EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

EIDP has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

SEC filer profile

How EIDP is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGAREIDP, Inc.2
  • CIK0000030554
  • Employer ID (EIN)82-497909610
  • Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company10
  • Incorporated inDelaware10
  • Fiscal year endsDecember 312
  • Industry code (SIC)2820 Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)2
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance2
  • Business address9330 Zionsville Road, Indianapolis, IN 462682
  • Phone83326783822
  • Shares outstanding672,524,000 shares; 200 EIDP shares as of Feb 5, 202610
  • Public float$50.6B as of Jun 30, 202510
  • AuditorPricewaterhouseCoopers LLP, Philadelphia, Pennsylvania PCAOB ID 238; it also attests to the company’s internal control over financial reporting10
  • On EDGAR sinceJan 6, 19942
  • Filings3,953 in all: 4 (2,679), 8-K (334), 11-K (109), 10-Q (98), 4/A (86), DEFA14A (72), 425 (59), DFAN14A (59)2
    All 57 form types

    424B3 (45), 3 (43), S-8 POS (33), 10-K (31), S-8 (30), UPLOAD (26), SC 13G/A (25), DEF 14A (23), SC 13D/A (18), CORRESP (17), FWP (14), NO ACT (13), 424B2 (12), PX14A6G (12), 424B5 (11), SC 13G (11), 3/A (8), 8-K/A (7), SC 13D (7), S-3 (6), S-3ASR (6), SD (6), S-3/A (5), SC 14D1/A (4), 10-Q/A (3), NT 11-K (3), PRRN14A (3), SC 13E4/A (3), 10-K405 (2), 10-K405/A (2), 5 (2), ARS (2), CB/A (2), DEFC14A (2), POSASR (2), PRE 14A (2), PREC14A (2), S-4/A (2), SC 13E4 (2), 10-K/A (1), 11-K/A (1), 25-NSE (1), 424B1 (1), CB (1), DEFM14A (1), DEFR14A (1), PRER14A (1), S-4 (1), SC 14D1 (1)

  • Latest filingsAnnual report (10-K) Feb 12, 2026
    Quarterly report (10-Q) Jul 31, 2026
    Proxy statement (DEF 14A) Apr 14, 2017
    Latest 8-K (8-K) Oct 13, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, par value $0.01 per shareCTVANew York Stock Exchange
$3.50 Series Preferred StockCTAPrANew York Stock Exchange
$4.50 Series Preferred StockCTAPrBNew York Stock Exchange

From the cover page of the 10-K filed Feb 12, 2026 (Section 12(b) of the Exchange Act).10

Risk factors and legal proceedings

The risks EIDP names in Item 1A of its 10-K filed Feb 12, 2026: 28 risks under these headings, as written.10

  • Risks Related to Our Industry
  • Corteva may not be able to obtain or maintain the necessary regulatory approvals for some of its products, including its seed and crop protection products, which could restrict its ability to sell those products in some markets.
  • The successful development and commercialization of Corteva's pipeline products will be necessary for Corteva's growth.
  • The degree of public understanding and acceptance or perceived public acceptance of Corteva’s biotechnology and other agricultural products and technologies can affect Corteva’s sales and results of operations by affecting planting approvals, regulatory requirements and customer purchase decisions.
  • Corteva’s business is subject to various competition and antitrust, rules and regulations around the world, and as the size of its business grows, scrutiny of its business by legislators and regulators in these areas may intensify.
  • Changes in agricultural and related policies of governments and international organizations may prove unfavorable.
  • The costs of complying with evolving regulatory requirements could negatively impact Corteva’s business, results of operations and financial condition. Actual or alleged violations of environmental laws or permit requirements could result in restrictions or prohibitions on plant operations, substantial civil or criminal sanctions, as well as the assessment of strict liability and/or joint and several liability.
  • Climate change and unpredictable seasonal and weather factors could impact Corteva’s sales and earnings.
  • Corteva participates in an industry that is highly competitive and has undergone consolidation, which could increase competitive pressures.
  • Recent funding and staff reductions, including at the EPA, the USDA, the FDA and the U.S. Department of Health and Human Services ("HHS"), could hinder our ability to receive timely regulatory approvals.
  • Corteva’s sales to its customers may be adversely affected should a company successfully establish an intermediary platform for the sale of Corteva’s products or otherwise position itself between Corteva and its customers.
  • Risks Related to Our Operations
The other 18 risks
  • Our business, financial condition and results of operations could be materially affected by disruptions in the global economy caused by geopolitical and military conflicts.
  • Volatility in Corteva’s input costs, which include raw materials and production costs, could have a significant impact on Corteva’s business, results of operations and financial condition.
  • Corteva’s operations outside the United States are subject to risks and restrictions, which could negatively affect Corteva’s business, results of operations and financial condition.
  • Corteva’s business, results of operations and financial condition could be adversely affected by industrial espionage and other disruptions to its supply chain, information technology or network systems.
  • Corteva’s business, results of operations and financial condition could be adversely affected by environmental, litigation and other commitments and contingencies.
  • Corteva is dependent on its relationships or contracts with third parties with respect to certain of its raw materials or licenses and commercialization.
  • Corteva’s customers may be unable to pay their debts to Corteva, which could adversely affect Corteva’s results.
  • Failure to effectively manage acquisitions, divestitures, strategic investments, restructurings, cost savings initiatives and other portfolio actions may not have the results anticipated.
  • Corteva’s liquidity, business, results of operations and financial condition could be impaired if it is unable to raise capital through the capital markets or short-term debt borrowings.
  • Increases in pension and other post-employment benefit plan funding obligations may adversely affect Corteva’s results of operations, liquidity or financial condition.
  • Global or regional health pandemics or epidemics could negatively impact the company's business, financial condition and results of operations.
  • Sentiment towards sustainability matters could adversely affect our stock price, results of operations, and access to capital.
  • Risks Related to Our Intellectual Property
  • Enforcing Corteva’s intellectual property rights, or defending against intellectual property claims asserted by others, could materially affect Corteva’s business, results of operations and financial condition.
  • Corteva’s business may be adversely affected by the availability of counterfeit products.
  • Restrictions under the intellectual property cross-license agreements limit Corteva’s ability to develop and commercialize certain products and services and/or prosecute, maintain and enforce certain intellectual property.
  • Risks Related to the Corteva Separation
  • The Corteva Separation and related transactions may expose Corteva to potential liabilities arising out of state and federal fraudulent conveyance laws
  • The company is subject to continuing contingent tax-related liabilities of DowDuPont following the Distribution.
  • Risks related to our Proposed Separation
  • Corteva is subject to risks related to its plans to separate its seed and crop protection businesses in a spin-off that will result in two standalone public companies, including that the proposed separation may not be completed on the contemplated timeline or at all and may not achieve the intended benefits.

Legal proceedings

The company is subject to various legal proceedings, including, but not limited to, product liability, intellectual property, antitrust, commercial, property damage, personal injury, environmental and regulatory matters arising out of the normal course of its current businesses or legacy EIDP businesses unrelated to Corteva’s current businesses but allocated to Corteva as part of the Corteva Separation from DuPont.

Often these proceedings raise complex factual and legal issues, which are subject to risks and uncertainties and which could require significant amounts of the senior leadership team’s time. Litigation and other claims, along with regulatory proceedings, against the company could also materially adversely affect its operations, reputation, and/or result in the incurrence of unexpected expenses and liability. Even when the company believes liabilities are not expected to be material or the probability of loss or of an adverse unappealable final judgment is remote, the company may consider settlement of these matters, and may enter into settlement agreements, if it believes settlement is in the best interest of the company, including avoidance of future distraction and litigation defense cost, and its shareholders. Information regarding certain of these matters is set forth below and in Note 15 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements.

Litigation related to Corteva’s current businesses

Inari Disputes

The opening of Item 3, Legal Proceedings.10

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
    SEC EDGAROther events
  72. 72
  73. 73